Vault-13

Nantahala Capital Management, LLC

NEW CANAAN, CT · CIK 1472322 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2011 · limited liability company

As an employer

$1.2bn reported value -20.2% vs Q1 2022
105positions
45.4%in top 10
11 new 29 added 50 reduced 12 sold out vs Q1 2022

Options: 10 call positions ($127.6m notional), 9 put positions ($712.5m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 2,007,385 $109.2m9.46% 9.46% ReducedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.0m -141.8k -141,816 -6.6%
2 UNIQURE NV SHS QURE QURE 3,090,757 $57.6m4.99% 4.99% AddedShares held: Q3 2021 1.8m, Q4 2021 2.4m, Q1 2022 2.8m, Q2 2022 3.1m +279.3k +279,298 9.9%
3 LIGHT & WONDER INC COM LNWO LNWO 1,111,338 $52.2m4.52% 4.52% ReducedShares held: Q3 2021 20.8k, Q4 2021 93.5k, Q1 2022 1.1m, Q2 2022 1.1m -33.3k -33,275 -2.9%
4 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,663,087 $51.2m4.44% 4.44% ReducedShares held: Q3 2021 2.7m, Q4 2021 2.9m, Q1 2022 2.7m, Q2 2022 2.7m -29.2k -29,216 -1.1%
5 IMAX CORP COM IMAX IMAX 2,729,441 $46.1m3.99% 3.99% AddedShares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.7m, Q2 2022 2.7m +61.0k +61,010 2.3%
6 MILLERKNOLL INC COM MLKN MLKN 1,707,739 $44.9m3.89% 3.89% AddedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.6m, Q2 2022 1.7m +84.6k +84,604 5.2%
7 TRAVELCENTERS OF AMERICA INC COM NEW TA TA 1,272,570 $43.9m3.80% 3.80% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.3m
8 CODEXIS INC COM CDXS CDXS 4,120,098 $43.1m3.73% 3.73% AddedShares held: Q3 2021 3.7m, Q4 2021 3.2m, Q1 2022 3.4m, Q2 2022 4.1m +737.0k +737,049 21.8%
9 PATHWARD FINANCIAL INC COM CASH CASH 985,459 $38.1m3.30% 3.30% AddedShares held: Q3 2021 1.2m, Q4 2021 895.8k, Q1 2022 870.0k, Q2 2022 985.5k +115.5k +115,466 13.3%
10 TRAVEL PLUS LEISURE CO COM TNL TNL 975,281 $37.9m3.28% 3.28% AddedShares held: Q3 2021 932.3k, Q4 2021 941.3k, Q1 2022 867.5k, Q2 2022 975.3k +107.8k +107,817 12.4%
11 DXP ENTERPRISES INC COM NEW DXPE DXPE 1,205,031 $36.9m3.20% 3.20% AddedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m +15.9k +15,852 1.3%
12 LUXFER HLDGS PLC SHS LXFR LXFR 2,327,801 $35.2m3.05% 3.05% AddedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.2m, Q2 2022 2.3m +95.4k +95,412 4.3%
13 COSTCO WHSL CORP NEW COM COST COST 71,495 $34.3m2.97% 2.97% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 71.5k
14 RMR GROUP INC CL A RMR RMR 970,623 $27.5m2.38% 2.38% AddedShares held: Q3 2021 626.8k, Q4 2021 963.7k, Q1 2022 961.9k, Q2 2022 970.6k +8.8k +8,772 0.9%
15 IMMATICS N.V SHS IMTX IMTX 3,121,759 $27.2m2.36% 2.36% AddedShares held: Q3 2021 2.6m, Q4 2021 2.9m, Q1 2022 2.9m, Q2 2022 3.1m +177.1k +177,100 6.0%
16 KEROS THERAPEUTICS INC COM KROS KROS 911,901 $25.2m2.18% 2.18% AddedShares held: Q3 2021 760.4k, Q4 2021 796.7k, Q1 2022 816.8k, Q2 2022 911.9k +95.1k +95,071 11.6%
17 RED VIOLET INC COM RDVT RDVT 1,291,771 $24.6m2.13% 2.13% AddedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.3m, Q2 2022 1.3m +30.5k +30,520 2.4%
18 PELOTON INTERACTIVE INC CL A COM PTON PTON 2,448,878 $22.5m1.95% 1.95% AddedShares held: Q3 2021 0, Q4 2021 102.3k, Q1 2022 590.3k, Q2 2022 2.4m +1.9m +1,858,548 314.8%
19 DHI GROUP INC COM DHX DHX 4,138,483 $20.6m1.78% 1.78% AddedShares held: Q3 2021 3.4m, Q4 2021 3.7m, Q1 2022 3.8m, Q2 2022 4.1m +290.7k +290,714 7.6%
20 PAYA HOLDINGS INC COM CL A PAYA PAYA 2,959,599 $19.4m1.68% 1.68% ReducedShares held: Q3 2021 1.5m, Q4 2021 3.8m, Q1 2022 4.1m, Q2 2022 3.0m -1.2m -1,150,474 -28.0%
21 GOLDEN ENTMT INC COM GDEN GDEN 484,974 $19.2m1.66% 1.66% ReducedShares held: Q3 2021 901.2k, Q4 2021 1.1m, Q1 2022 690.6k, Q2 2022 485.0k -205.6k -205,632 -29.8%
22 RH COM RH RH 90,000 $19.1m1.66% 1.66% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 90.0k
23 MEDIAALPHA INC CL A MAX MAX 1,640,624 $16.2m1.40% 1.40% AddedShares held: Q3 2021 0, Q4 2021 370.4k, Q1 2022 437.5k, Q2 2022 1.6m +1.2m +1,203,130 275.0%
24 ALTA EQUIPMENT GROUP INC COMMON STOCK ALTG ALTG 1,672,545 $15.0m1.30% 1.30% ReducedShares held: Q3 2021 1.9m, Q4 2021 1.9m, Q1 2022 1.8m, Q2 2022 1.7m -134.1k -134,062 -7.4%
25 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 5,142,855 $14.6m1.26% 1.26% AddedShares held: Q3 2021 2.9m, Q4 2021 4.1m, Q1 2022 4.3m, Q2 2022 5.1m +796.5k +796,528 18.3%
26 APOLLO ENDOSURGERY INC COM COM 3,723,010 $13.6m1.18% 1.18% ReducedShares held: Q3 2021 2.5m, Q4 2021 3.8m, Q1 2022 3.7m, Q2 2022 3.7m -1.9k -1,889 -0.1%
27 LYRA THERAPEUTICS INC COM LYRA LYRA 2,369,668 $13.4m1.16% 1.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.4m
28 READING INTERNATIONAL INC CL A RDI RDI 3,207,247 $11.6m1.00% 1.00% ReducedShares held: Q3 2021 3.5m, Q4 2021 3.5m, Q1 2022 3.2m, Q2 2022 3.2m -19.4k -19,409 -0.6%
29 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 1,562,458 $10.9m0.95% 0.95% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.1m, Q2 2022 1.6m +490.9k +490,922 45.8%
30 DARIOHEALTH CORP COM NEW DRIO DRIO 1,730,810 $10.6m0.92% 0.92% AddedShares held: Q3 2021 1.1m, Q4 2021 1.4m, Q1 2022 1.7m, Q2 2022 1.7m +14.8k +14,803 0.9%
31 BBQ HLDGS INC COM COM 948,254 $9.9m0.86% 0.86% ReducedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 951.6k, Q2 2022 948.3k -3.3k -3,305 -0.3%
32 SEMLER SCIENTIFIC INC COM SMLR SMLR 346,606 $9.8m0.85% 0.85% ReducedShares held: Q3 2021 145.4k, Q4 2021 279.1k, Q1 2022 356.9k, Q2 2022 346.6k -10.3k -10,269 -2.9%
33 INSU ACQUISITION CORP III COM CL A COM CL A 980,183 $9.7m0.84% 0.84% ReducedShares held: Q3 2021 1,000.0k, Q4 2021 1,000.0k, Q1 2022 995.2k, Q2 2022 980.2k -15.0k -14,990 -1.5%
34 VIEMED HEALTHCARE INC COM VMD VMD 1,714,926 $9.2m0.80% 0.80% AddedShares held: Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.3m, Q2 2022 1.7m +421.1k +421,114 32.5%
35 ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS CLASS A ORD SHS 862,566 $8.4m0.73% 0.73% ReducedShares held: Q3 2021 1.0m, Q4 2021 999.8k, Q1 2022 865.6k, Q2 2022 862.6k -3.1k -3,067 -0.3%
36 RINGCENTRAL INC CL A RNG RNG 150,000 $7.8m0.68% 0.68% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 150.0k
37 CYMABAY THERAPEUTICS INC COM CBAY CBAY 2,644,306 $7.8m0.68% 0.68% AddedShares held: Q3 2021 0, Q4 2021 2.0m, Q1 2022 1.9m, Q2 2022 2.6m +750.3k +750,309 39.6%
38 FTAC HERA ACQUISITION CORP CLASS A ORD SHS CLASS A ORD SHS 787,130 $7.7m0.67% 0.67% ReducedShares held: Q3 2021 1,000.0k, Q4 2021 931.2k, Q1 2022 800.0k, Q2 2022 787.1k -12.9k -12,871 -1.6%
39 FORTRESS BIOTECH INC COM COM 8,758,648 $7.4m0.64% 0.64% ReducedShares held: Q3 2021 8.1m, Q4 2021 9.1m, Q1 2022 8.8m, Q2 2022 8.8m -83.9k -83,877 -0.9%
40 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 1,659,840 $7.0m0.61% 0.61% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.7m
41 PAR TECHNOLOGY CORP NOTE 2.875% 4/1 · principal PAR 2.875 04.15.26 · principal PAR 2.875 04.15.26 5,785,000 $6.7m0.58% 0.58% UnchangedPrincipal held: Q3 2021 6.0m, Q4 2021 6.0m, Q1 2022 5.8m, Q2 2022 5.8m
42 SCULLY ROYALTY LTD COM SHS SRL SRL 771,196 $6.2m0.54% 0.54% ReducedShares held: Q3 2021 752.4k, Q4 2021 807.1k, Q1 2022 772.4k, Q2 2022 771.2k -1.2k -1,241 -0.2%
43 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 1,643,438 $6.1m0.53% 0.53% AddedShares held: Q3 2021 1.2m, Q4 2021 1.5m, Q1 2022 1.3m, Q2 2022 1.6m +309.5k +309,491 23.2%
44 ARS PHARMACEUTICALS INC COM SPRY SPRY 1,386,138 $5.9m0.51% 0.51% AddedShares held: Q3 2021 1.2m, Q4 2021 1.0m, Q1 2022 913.6k, Q2 2022 1.4m +472.5k +472,541 51.7%
45 ON24 INC COM ONTF ONTF 570,403 $5.4m0.47% 0.47% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 384.1k, Q2 2022 570.4k +186.3k +186,315 48.5%
46 APTOSE BIOSCIENCES INC COM NEW COM NEW 7,232,676 $5.4m0.47% 0.47% ReducedShares held: Q3 2021 7.4m, Q4 2021 7.6m, Q1 2022 7.3m, Q2 2022 7.2m -89.5k -89,513 -1.2%
47 CATALYST BIOSCIENCES INC COM NEW COM NEW 2,755,903 $4.9m0.43% 0.43% AddedShares held: Q3 2021 2.4m, Q4 2021 2.8m, Q1 2022 2.4m, Q2 2022 2.8m +335.1k +335,114 13.8%
48 AURA BIOSCIENCES INC COM AURA AURA 343,215 $4.9m0.42% 0.42% AddedShares held: Q3 2021 0, Q4 2021 99.1k, Q1 2022 302.0k, Q2 2022 343.2k +41.2k +41,225 13.7%
49 STRYKER CORPORATION COM SYK SYK 23,000 $4.6m0.40% 0.40% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 23.0k
50 STRATA SKIN SCIENCES INC COM NEW SSKN SSKN 4,575,812 $4.4m0.38% 0.38% UnchangedShares held: Q3 2021 4.6m, Q4 2021 4.6m, Q1 2022 4.6m, Q2 2022 4.6m
51 ISHARES TR RUSSELL 2000 ETF IWM IWM 23,873 $4.0m0.35% 0.35% ReducedShares held: Q3 2021 99.6k, Q4 2021 42.6k, Q1 2022 368.0k, Q2 2022 23.9k -344.2k -344,156 -93.5%
52 CURIS INC COM NEW COM NEW 3,628,162 $3.6m0.31% 0.31% AddedShares held: Q3 2021 2.5m, Q4 2021 2.4m, Q1 2022 2.5m, Q2 2022 3.6m +1.1m +1,149,897 46.4%
53 INMODE LTD SHS INMD INMD 158,154 $3.5m0.31% 0.31% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 158.2k
54 AVALO THERAPEUTICS INC COM COM 6,710,327 $3.4m0.29% 0.29% ReducedShares held: Q3 2021 7.0m, Q4 2021 7.1m, Q1 2022 6.8m, Q2 2022 6.7m -139.2k -139,220 -2.0%
55 AKUMIN INC COM COM 5,545,233 $3.3m0.29% 0.29% ReducedShares held: Q3 2021 6.3m, Q4 2021 6.3m, Q1 2022 5.6m, Q2 2022 5.5m -33.8k -33,759 -0.6%
56 B. RILEY FINANCIAL INC COM RILY RILY 77,083 $3.3m0.28% 0.28% ReducedShares held: Q3 2021 93.8k, Q4 2021 93.4k, Q1 2022 78.5k, Q2 2022 77.1k -1.4k -1,425 -1.8%
57 ARYA SCIENCES ACQU CORP IV CL A CL A 322,929 $3.2m0.27% 0.27% ReducedShares held: Q3 2021 399.2k, Q4 2021 399.2k, Q1 2022 325.8k, Q2 2022 322.9k -2.9k -2,919 -0.9%
58 B RILEY PRINCIPAL 150 MERGER COM CL A COM CL A 297,727 $3.0m0.26% 0.26% ReducedShares held: Q3 2021 0, Q4 2021 349.6k, Q1 2022 301.8k, Q2 2022 297.7k -4.1k -4,059 -1.3%
59 RUMBLEON INC COM CL B RDNW RDNW 200,000 $2.9m0.25% 0.25% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 200.0k
60 PERELLA WEINBERG PARTNERS CLASS A COM PWP PWP 502,676 $2.9m0.25% 0.25% UnchangedShares held: Q3 2021 480.8k, Q4 2021 278.1k, Q1 2022 502.7k, Q2 2022 502.7k
61 MERRIMACK PHARMACEUTICALS IN COM NEW MACK MACK 491,509 $2.9m0.25% 0.25% ReducedShares held: Q3 2021 570.0k, Q4 2021 570.0k, Q1 2022 516.8k, Q2 2022 491.5k -25.3k -25,308 -4.9%
62 NEURONETICS INC COM STIM STIM 767,400 $2.5m0.21% 0.21% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 880.2k, Q2 2022 767.4k -112.8k -112,755 -12.8%
63 NEUROPACE INC COM NPCE NPCE 478,438 $2.4m0.21% 0.21% ReducedShares held: Q3 2021 141.6k, Q4 2021 305.9k, Q1 2022 485.3k, Q2 2022 478.4k -6.9k -6,865 -1.4%
64 CIDARA THERAPEUTICS INC COM COM 4,819,090 $2.4m0.20% 0.20% ReducedShares held: Q3 2021 0, Q4 2021 5.3m, Q1 2022 5.0m, Q2 2022 4.8m -135.8k -135,792 -2.7%
65 IMMATICS N.V *W EXP 07/01/202 IMTXW IMTXW 1,035,613 $2.1m0.18% 0.18% UnchangedShares held: Q3 2021 226.5k, Q4 2021 1.1m, Q1 2022 1.0m, Q2 2022 1.0m
66 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 784,798 $2.1m0.18% 0.18% ReducedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 893.6k, Q2 2022 784.8k -108.8k -108,763 -12.2%
67 AEGLEA BIOTHERAPEUTICS INC COM AGLE AGLE 3,877,311 $2.0m0.17% 0.17% AddedShares held: Q3 2021 1.5m, Q4 2021 2.8m, Q1 2022 3.2m, Q2 2022 3.9m +676.7k +676,718 21.1%
68 SHIFT TECHNOLOGIES INC CL A CL A 2,662,933 $1.8m0.16% 0.16% ReducedShares held: Q3 2021 4.5m, Q4 2021 4.1m, Q1 2022 3.7m, Q2 2022 2.7m -1.1m -1,067,979 -28.6%
69 SOLENO THERAPEUTICS INC COM NEW SLNO SLNO 9,436,512 $1.7m0.15% 0.15% UnchangedShares held: Q3 2021 9.8m, Q4 2021 9.8m, Q1 2022 9.4m, Q2 2022 9.4m
70 ZOVIO INC COM ZVOI ZVOI 1,655,335 $1.6m0.14% 0.14% ReducedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 2.6m, Q2 2022 1.7m -958.4k -958,428 -36.7%
71 5 01 ACQUISITION CORP COM CL A COM CL A 157,044 $1.6m0.13% 0.13% ReducedShares held: Q3 2021 185.2k, Q4 2021 181.9k, Q1 2022 162.4k, Q2 2022 157.0k -5.4k -5,386 -3.3%
72 PAYONEER GLOBAL INC COM PAYO PAYO 385,366 $1.5m0.13% 0.13% UnchangedShares held: Q3 2021 655.2k, Q4 2021 398.7k, Q1 2022 385.4k, Q2 2022 385.4k
73 IDW MEDIA HLDGS INC CL B CL B 1,052,852 $1.4m0.12% 0.12% ReducedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.1m, Q2 2022 1.1m -65.6k -65,554 -5.9%
74 ANGION BIOMEDICA CORP COM COM 1,131,001 $1.3m0.11% 0.11% ReducedShares held: Q3 2021 118.5k, Q4 2021 1.3m, Q1 2022 1.2m, Q2 2022 1.1m -42.2k -42,161 -3.6%
75 HYPERFINE INC COM CL A HYPR HYPR 544,930 $1.2m0.11% 0.11% ReducedShares held: Q3 2021 0, Q4 2021 718.6k, Q1 2022 596.5k, Q2 2022 544.9k -51.5k -51,550 -8.6%
76 IMAC HLDGS INC COM COM 1,259,379 $1.0m0.09% 0.09% ReducedShares held: Q3 2021 2.4m, Q4 2021 2.4m, Q1 2022 2.2m, Q2 2022 1.3m -981.7k -981,734 -43.8%
77 LAVA THERAPEUTICS NV SHS LVTX LVTX 322,980 $953.0k0.08% 0.08% ReducedShares held: Q3 2021 369.3k, Q4 2021 360.8k, Q1 2022 334.2k, Q2 2022 323.0k -11.2k -11,184 -3.4%
78 ALECTOR INC COM ALEC ALEC 92,176 $937.0k0.08% 0.08% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 94.8k, Q2 2022 92.2k -2.6k -2,603 -2.8%
79 ACER THERAPEUTICS INC COM OPXA OPXA 741,010 $934.0k0.08% 0.08% ReducedShares held: Q3 2021 914.2k, Q4 2021 901.3k, Q1 2022 777.8k, Q2 2022 741.0k -36.8k -36,810 -4.7%
80 IMV INC COM COM 1,424,676 $933.0k0.08% 0.08% ReducedShares held: Q3 2021 2.3m, Q4 2021 2.1m, Q1 2022 1.9m, Q2 2022 1.4m -441.8k -441,815 -23.7%
81 HELIOGEN INC COMMON STOCK COMMON STOCK 433,909 $916.0k0.08% 0.08% ReducedShares held: Q3 2021 0, Q4 2021 775.0k, Q1 2022 643.6k, Q2 2022 433.9k -209.7k -209,690 -32.6%
82 FARADAY FUTRE INTLGT ELCTR I COM COM 350,000 $910.0k0.08% 0.08% UnchangedShares held: Q3 2021 350.0k, Q4 2021 350.0k, Q1 2022 350.0k, Q2 2022 350.0k
83 EXAGEN INC COM XGN XGN 156,135 $896.0k0.08% 0.08% ReducedShares held: Q3 2021 211.6k, Q4 2021 186.9k, Q1 2022 159.3k, Q2 2022 156.1k -3.1k -3,118 -2.0%
84 EARGO INC COM COM 1,028,965 $774.0k0.07% 0.07% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
85 LUCID DIAGNOSTICS INC COM LUCD LUCD 308,978 $698.0k0.06% 0.06% ReducedShares held: Q3 2021 0, Q4 2021 435.1k, Q1 2022 315.4k, Q2 2022 309.0k -6.4k -6,436 -2.0%
86 UNICYCIVE THERAPEUTICS INC COM COM 729,680 $606.0k0.05% 0.05% AddedShares held: Q3 2021 700.0k, Q4 2021 686.8k, Q1 2022 640.6k, Q2 2022 729.7k +89.0k +89,047 13.9%
87 COGNITION THERAPEUTICS INC COM CGTX CGTX 192,752 $407.0k0.04% 0.04% ReducedShares held: Q3 2021 0, Q4 2021 209.6k, Q1 2022 196.4k, Q2 2022 192.8k -3.6k -3,650 -1.9%
88 IN8BIO INC COM INAB INAB 148,801 $359.0k0.03% 0.03% ReducedShares held: Q3 2021 375.0k, Q4 2021 373.2k, Q1 2022 352.8k, Q2 2022 148.8k -204.0k -203,952 -57.8%
89 METROMILE INC COM COM 325,002 $298.0k0.03% 0.03% ReducedShares held: Q3 2021 1.9m, Q4 2021 1.1m, Q1 2022 1.0m, Q2 2022 325.0k -718.5k -718,512 -68.9%
90 TRANSACT TECHNOLOGIES INC COM TACT TACT 69,991 $279.0k0.02% 0.02% ReducedShares held: Q3 2021 76.6k, Q4 2021 76.6k, Q1 2022 71.3k, Q2 2022 70.0k -1.3k -1,344 -1.9%
91 PERELLA WEINBERG PARTNERS *W EXP 12/31/202 *W EXP 12/31/202 409,128 $264.0k0.02% 0.02% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 409.1k, Q2 2022 409.1k
92 CUE BIOPHARMA INC COM COM 100,464 $250.0k0.02% 0.02% ReducedShares held: Q3 2021 2.6m, Q4 2021 2.5m, Q1 2022 2.2m, Q2 2022 100.5k -2.1m -2,143,895 -95.5%
93 WEJO GROUP LIMITED COMMON SHARES WEJOF WEJOF 132,728 $158.0k0.01% 0.01% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 215.0k, Q2 2022 132.7k -82.2k -82,238 -38.3%
94 SITIO ROYALTIES CORP *W EXP 08/23/202 *W EXP 08/23/202 582,350 $93.0k0.01% 0.01% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 582.4k
95 B RILEY PRINCIPAL 150 MERGER *W EXP 03/01/202 *W EXP 03/01/202 185,653 $69.0k0.01% 0.01% AddedShares held: Q3 2021 0, Q4 2021 125.0k, Q1 2022 120.7k, Q2 2022 185.7k +65.0k +64,967 53.8%
96 METROMILE INC *W EXP 02/09/202 *W EXP 02/09/202 507,460 $57.0k0.00% 0.00% UnchangedShares held: Q3 2021 558.3k, Q4 2021 558.3k, Q1 2022 507.5k, Q2 2022 507.5k
97 TC BIOPHARM HOLDINGS PLC *W EXP 02/10/202 TCBWF TCBWF 235,294 $56.0k0.00% 0.00% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 235.3k, Q2 2022 235.3k
98 FTAC HERA ACQUISITION CORP *W EXP 02/28/202 *W EXP 02/28/202 222,949 $53.0k0.00% 0.00% UnchangedShares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 222.9k, Q2 2022 222.9k
99 FINTECH ACQUISITION CORP VI *W EXP 03/31/202 *W EXP 03/31/202 240,600 $39.0k0.00% 0.00% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 250.0k, Q2 2022 240.6k -9.4k -9,398 -3.8%
100 RAFAEL HLDGS INC COM CL B RFL RFL 19,435 $36.0k0.00% 0.00% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 19.4k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
INTERNATIONAL MNY EXPRESS IN IMXI IMXI 1,425,985 $29.4m1.4m shares
FINTECH ACQUISITION CORP VI 999,992 $9.8m1,000.0k shares
FINTECH ACQUISITION CORP V 958,137 $9.5m958.1k shares
HCA HEALTHCARE INC HCA HCA 35,600 $8.9m35.6k shares
WAYFAIR INC W W 34,688 $3.8m34.7k shares
WAVE LIFE SCIENCES LTD 96663EUR 96663EUR 819,101 $1.6m819.1k shares
TANGO THERAPEUTICS INC TNGX TNGX 98,794 $749.0k98.8k shares
ELOXX PHARMACEUTICALS INC 774,767 $434.0k774.8k shares
GALMED PHARMACEUTICALS LTD 258,957 $412.0k259.0k shares
HTG MOLECULAR DIAGNOSTICS IN 285,963 $397.0k286.0k shares
FALCON MINERALS CORP 674,561 $256.0k674.6k shares
OCUGEN INC OCGN OCGN 16,571 $55.0k16.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ISHARES TR IWM · Put IWMPut 2,500,000 $423.4m2.5m shares Reduced
ELI LILLY & CO LLY · Put LLYPut 350,000 $113.5m350.0k shares New
COSTCO WHSL CORP NEW COST · Put COSTPut 100,000 $47.9m100.0k shares New
IMAX CORP IMAX · Call IMAXCall 2,191,300 $37.0m2.2m shares Unchanged
TRAVEL PLUS LEISURE CO TNL · Call TNLCall 919,100 $35.7m919.1k shares Unchanged
AMPHASTAR PHARMACEUTICALS IN AMPH · Put AMPHPut 1,000,000 $34.8m1.0m shares Unchanged
ADTALEM GLOBAL ED INC CVSA · Put CVSAPut 900,000 $32.4m900.0k shares Added
STRYKER CORPORATION SYK · Put SYKPut 120,000 $23.9m120.0k shares Added
DARDEN RESTAURANTS INC DRI · Put DRIPut 200,000 $22.6m200.0k shares Added
HERBALIFE NUTRITION LTD HLF · Call HLFCall 867,700 $17.7m867.7k shares Added
UNIQURE NV QURE · Call QURECall 800,000 $14.9m800.0k shares Reduced
PELOTON INTERACTIVE INC PTON · Call PTONCall 1,138,600 $10.5m1.1m shares Added
GOGO INC GOGO · Put GOGOPut 500,000 $8.1m500.0k shares New
PERDOCEO ED CORP PRDO · Put PRDOPut 500,000 $5.9m500.0k shares New
APOLLO ENDOSURGERY INC Call Call 1,600,000 $5.8m1.6m shares New
KROGER CO KR · Call KRCall 50,000 $2.4m50.0k shares New
VROOM INC VRM · Call VRMCall 1,500,000 $1.9m1.5m shares Unchanged
KEROS THERAPEUTICS INC KROS · Call KROSCall 41,900 $1.2m41.9k shares Unchanged
CODEXIS INC CDXS · Call CDXSCall 50,000 $523.0k50.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 63.

CompanyTickerStakeChange ScheduleLast filed
XTANT MED HLDGS INC XTNT · 13D · filed 2025-08-05 XTNT 49.1%≈ $28.8m no change 13D 2025-08-05
EAGLE PHARMACEUTICALS INC EGRX · 13G · filed 2025-08-14 EGRX 38.1% no change 13G 2025-08-14
EVOKE PHARMA INC 13D · filed 2025-02-03 16.0% 13D 2025-02-03
AYTU BIOPHARMA INC AYTU · 13D · filed 2025-06-09 AYTU 14.4%≈ $2.3m 13D 2025-06-09
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-10-07 RACC 14.1%≈ $11.8m new 13G 2026-10-07
TELA BIO INC TELA · 13G · filed 2026-08-14 TELA 12.9%≈ $4.3m no change 13G 2026-08-14
TALPHERA INC TLPH · 13D · filed 2025-04-03 TLPH 11.7%≈ $2.1m no change 13D 2025-04-03
ASSERTIO HOLDINGS INC 13G · filed 2026-04-07 10.7% +1.4 pts 13G 2026-04-07
UNICYCIVE THERAPEUTICS INC UNCY · 13G · filed 2026-08-14 UNCY 10.0%≈ $13.2m no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-14 KPRX 10.0%≈ $1.3m no change 13G 2026-08-14
AZITRA INC AZTR · 13G · filed 2026-08-14 AZTR 10.0%≈ $1.1m new 13G 2026-08-14
FOSSIL GROUP INC FOSL · 13G · filed 2026-05-15 FOSL 10.0%≈ $24.3m +0.5 pts 13G 2026-05-15
FRACTYL HEALTH INC 13G · filed 2026-05-15 10.0%≈ $12.8m no change 13G 2026-05-15
INSPIREMD INC NSPR · 13G · filed 2026-05-15 NSPR 10.0%≈ $3.4m no change 13G 2026-05-15
ENVOY MEDICAL INC COCH · 13G · filed 2026-05-15 COCH 10.0%≈ $6.1m new 13G 2026-05-15
ABEONA THERAPEUTICS INC ABEO · 13G · filed 2026-05-15 ABEO 10.0%≈ $35.7m no change 13G 2026-05-15
CURIS INC 13G · filed 2026-04-24 10.0%≈ $2.2m no change 13G 2026-04-24
APYX MEDICAL CORPORATION APYX · 13G · filed 2026-02-13 APYX 10.0%≈ $18.5m no change 13G 2026-02-13
DARIOHEALTH CORP DRIO · 13G · filed 2026-02-13 DRIO 10.0%≈ $4.5m no change 13G 2026-02-13
ELUTIA INC ELUT · 13G · filed 2026-02-13 ELUT 10.0%≈ $4.0m no change 13G 2026-02-13
UNICYCIVE THERAPEUTICS INC 13G · filed 2025-11-14 10.0% no change 13G 2025-11-14
DARIOHEALTH CORP DRIO · 13G · filed 2025-08-14 DRIO 10.0% no change 13G 2025-08-14
BIOMX INC 13G · filed 2025-05-15 10.0% no change 13G 2025-05-15
OPTINOSE INC 13G · filed 2024-11-14 10.0% new 13G 2024-11-14
ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-08-14 ELOX 9.9%≈ $5.6m new 13G 2026-08-14